Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Horowitz

Showing results (51-60 of 260) with videos related to

Pageof 26
Sort By:
Cancer|June 22, 2010
Access to hematopoietic stem cell transplantation: effect of race and sexThomas V Joshua, J Douglas Rizzo, Mei-Jie Zhang, et al.
Chest|July 9, 2005
Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemiaLinus H Santo Tomas, Fausto R Loberiza, John P Klein, et al.
Blood|February 3, 2007
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimensRichard E Champlin, Waleska S Perez, Jakob R Passweg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplantHillard M Lazarus, Fangyu Kan, Sergey Tarima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and CanadaDerek S Serna, Stephanie J Lee, Mei-jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2015
Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research StudyMohamed L Sorror, Brent R Logan, Xiaochun Zhu, et al.
Blood|July 13, 2013
Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)Wael Saber, Corey S Cutler, Ryotaro Nakamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2014
Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methodsWael Saber, Jennifer Le Rademacher, Mikkael Sekeres, et al.
Blood|May 19, 2012
A perspective on the selection of unrelated donors and cord blood units for transplantationStephen R Spellman, Mary Eapen, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 5, 2011
Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trialsEllen M Denzen, Martha E Burton Santibáñez, Heather Moore, et al.
Pageof 26

Showing results (51-60 of 260) with videos related to

Sort By:
Pageof 26
Cancer|June 22, 2010
Access to hematopoietic stem cell transplantation: effect of race and sexThomas V Joshua, J Douglas Rizzo, Mei-Jie Zhang, et al.
Chest|July 9, 2005
Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemiaLinus H Santo Tomas, Fausto R Loberiza, John P Klein, et al.
Blood|February 3, 2007
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimensRichard E Champlin, Waleska S Perez, Jakob R Passweg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplantHillard M Lazarus, Fangyu Kan, Sergey Tarima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and CanadaDerek S Serna, Stephanie J Lee, Mei-jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2015
Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research StudyMohamed L Sorror, Brent R Logan, Xiaochun Zhu, et al.
Blood|July 13, 2013
Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)Wael Saber, Corey S Cutler, Ryotaro Nakamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2014
Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methodsWael Saber, Jennifer Le Rademacher, Mikkael Sekeres, et al.
Blood|May 19, 2012
A perspective on the selection of unrelated donors and cord blood units for transplantationStephen R Spellman, Mary Eapen, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 5, 2011
Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trialsEllen M Denzen, Martha E Burton Santibáñez, Heather Moore, et al.
Pageof 26